Furthermore, recent studies have demonstrated that BMP inhibition in PS19 mice reduces tau pathology and slows cognitive decline [28], further suggesting a key regulatory role for BMP signaling in the development and progression of Alzheimer’s disease. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.